RESUMEN
BACKGROUND: In natalizumab-treated relapsing-remitting MS (RRMS) patients, various extended interval dosing strategies are under evaluation to minimize severe treatment-associated side effects, mainly progressive multifocal leukoencephalopathy development. Up to now, it has not been presented any approach, even in form of assay design, to determine the optimal percentage of CD49d receptor occupancy (RO) associated with a favorable clinical, radiological, and immunological response. METHODS: A multiparametric quantitative flow cytometry method was settled to measure CD49d RO on peripheral blood lymphocytes. The analytical protocol was tested in a 6-month follow-up from 19 RRMS patients treated with the natalizumab standard dosing of every 4 weeks or an extended-interval dosing of every 6 weeks. RESULTS: Extended natalizumab dose schedule promoted an increase of CD49d molecules per cell surface and a reduction of CD49d RO levels. The reduction observed on CD49d RO was not only depending on dose schedule but also on individual parameters such as body mass. Interestingly, individual clinical outcome was apparently the same between the different dose schedules or even better with the extended interval dosing. CONCLUSIONS: Following up CD49d RO levels with a well-regulated monitoring work scheme is crucial to further identify over-/under-treated patients and to define a safe, personalized natalizumab regimen. © 2017 International Clinical Cytometry Society.
Asunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Integrina alfa4/metabolismo , Esclerosis Múltiple/tratamiento farmacológico , Esclerosis Múltiple/metabolismo , Natalizumab/uso terapéutico , Adulto , Femenino , Citometría de Flujo/métodos , Humanos , Leucoencefalopatía Multifocal Progresiva/tratamiento farmacológico , Leucoencefalopatía Multifocal Progresiva/metabolismo , Linfocitos/efectos de los fármacos , Linfocitos/metabolismo , Masculino , Estudios Prospectivos , RecurrenciaRESUMEN
INTRODUCTION. Anabolic-androgenic steroids are synthetic substances derived from testosterone that are employed for their trophic effect on muscle tissue, among other uses. Their consumption can give trigger a series of adverse side effects on the body, including the suppression of the hypothalamus-pituitary-gonadal axis as well as liver, psychiatric and cardiovascular disorders. The most common effects are altered fat profiles and blood pressure values, cardiac remodelling, arrhythmias or myocardial infarcts. CASE REPORT. We report the case of a young male, with a background of anabolic-androgenic steroids abuse, who visited because of an acute neurological focus in the right hemisphere related with an ischaemic stroke. The aetiological study, including cardiac monitoring, echocardiograph and imaging studies (magnetic resonance and arteriography) and lab findings (thrombophilia, serology, autoimmunity, tumour markers) showed no alterations. CONCLUSIONS. The association between consumption of anabolic-androgenic steroids and cardiovascular pathologies is known, but its relation with cerebrovascular disease has not received so much attention from researchers.
Asunto(s)
Anabolizantes/efectos adversos , Doping en los Deportes , Infarto de la Arteria Cerebral Media/inducido químicamente , Esteroides/efectos adversos , Trastornos Relacionados con Sustancias/complicaciones , Adulto , Alcoholismo/complicaciones , Isquemia Encefálica/inducido químicamente , Angiografía Cerebral , Clenbuterol/efectos adversos , Fibrinolíticos/uso terapéutico , Humanos , Infarto de la Arteria Cerebral Media/diagnóstico por imagen , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Infarto de la Arteria Cerebral Media/terapia , Masculino , Artes Marciales , Trombolisis Mecánica , Naltrexona/uso terapéutico , Nandrolona/efectos adversos , Nandrolona/análogos & derivados , Nandrolona Decanoato , Estanozolol/efectos adversos , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Propionato de Testosterona/efectos adversos , Activador de Tejido Plasminógeno/uso terapéutico , Tomografía Computarizada por Rayos XRESUMEN
Introducción. Los esteroides androgénicos anabólicos son sustancias sintéticas derivadas de la testosterona, utilizados, entre otros usos, por su efecto trófico sobre el tejido muscular. Su consumo puede producir una serie de efectos adversos sobre el organismo, entre los que destacan la supresión del eje hipotálamo-pituitario-gonadal, alteraciones hepáticas, psiquiátricas y cardiovasculares, y los efectos más frecuentes al respecto son la alteración del perfil lipídico y de las cifras tensionales, la remodelación cardíaca, la producción de arritmias o el infarto de miocardio. Caso clínico. Varón joven, con antecedentes de abuso de esteroides androgénicos anabólicos, que consulta por focalidad neurológica hemisférica derecha aguda en relación con un ictus isquémico. El estudio etiológico, incluyendo monitorización cardíaca, estudio ecocardiográfico, de imagen (resonancia magnética y arteriografía) y analítico (trombofilia, serologías, autoinmunidad, marcadores tumorales), no mostró alteraciones. Conclusiones. La asociación entre consumo de esteroides androgénicos anabólicos y patología cardiovascular es conocida,pero no se ha estudiado tanto su relación con la patología cerebrovascular (AU)
Introduction. Anabolic-androgenic steroids are synthetic substances derived from testosterone that are employed for their trophic effect on muscle tissue, among other uses. Their consumption can give trigger a series of adverse side effects on the body, including the suppression of the hypothalamus-pituitary-gonadal axis as well as liver, psychiatric and cardiovascular disorders. The most common effects are altered fat profiles and blood pressure values, cardiac remodelling, arrhythmias or myocardial infarcts. Case report. We report the case of a young male, with a background of anabolic-androgenic steroids abuse, who visited because of an acute neurological focus in the right hemisphere related with an ischaemic stroke. The aetiological study, including cardiac monitoring, echocardiograph and imaging studies (magnetic resonance and arteriography) and lab findings (thrombophilia, serology, autoimmunity, tumour markers) showed no alterations. Conclusions. The association between consumption of anabolic-androgenic steroids and cardiovascular pathologies is known, but its relation with cerebrovascular disease has not received so much attention from researchers (AU)